PMC:7264932
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2 | 0-32 | Disease | denotes | Invasive pulmonary aspergillosis | MESH:D055744 |
3 | 43-77 | Disease | denotes | coronavirus disease 2019 pneumonia | MESH:C000657245 |
8 | 234-242 | Species | denotes | patients | Tax:9606 |
9 | 121-153 | Disease | denotes | invasive pulmonary aspergillosis | MESH:D055744 |
10 | 200-215 | Disease | denotes | viral pneumonia | |
11 | 219-233 | Disease | denotes | critically ill | MESH:D016638 |
16 | 296-320 | Disease | denotes | coronavirus disease 2019 | MESH:C000657245 |
17 | 322-330 | Disease | denotes | COVID-19 | MESH:C000657245 |
18 | 344-379 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
19 | 563-583 | Disease | denotes | secondary infections | MESH:D060085 |
25 | 624-632 | Species | denotes | patients | Tax:9606 |
26 | 749-758 | Species | denotes | influenza | Tax:11309 |
27 | 609-623 | Disease | denotes | critically ill | MESH:D016638 |
28 | 694-712 | Disease | denotes | COVID-19 pneumonia | MESH:C000657245 |
29 | 759-768 | Disease | denotes | pneumonia | MESH:D011014 |
35 | 835-842 | Chemical | denotes | steroid | MESH:D013256 |
36 | 857-881 | Disease | denotes | other immunospuppression | MESH:D058497 |
37 | 937-946 | Disease | denotes | pneumonia | MESH:D011014 |
38 | 957-965 | Disease | denotes | COVID-19 | MESH:C000657245 |
39 | 1027-1062 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
50 | 2116-2119 | Gene | denotes | CRP | Gene:1401 |
51 | 2136-2140 | Gene | denotes | IL-6 | Gene:3569 |
52 | 1751-1758 | Species | denotes | Patient | Tax:9606 |
53 | 1807-1814 | Species | denotes | Patient | Tax:9606 |
54 | 1982-2003 | Species | denotes | Aspergillus fumigatus | Tax:746128 |
55 | 2004-2025 | Species | denotes | Aspergillus fumigatus | Tax:746128 |
56 | 2026-2036 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
57 | 1787-1805 | Disease | denotes | pulmonary fibrosis | MESH:D011658 |
58 | 2281-2294 | Disease | denotes | Renal failure | MESH:D051437 |
59 | 2330-2362 | Disease | denotes | invasive pulmonary aspergillosis | MESH:D055744 |
61 | 1681-1694 | Chemical | denotes | galactomannan | MESH:C012990 |
66 | 2413-2416 | Gene | denotes | CRP | Gene:1401 |
67 | 2418-2436 | Gene | denotes | C-reactive protein | Gene:1401 |
68 | 2438-2442 | Gene | denotes | IL-6 | Gene:3569 |
69 | 2464-2496 | Disease | denotes | invasive pulmonary aspergillosis | MESH:D055744 |
79 | 1110-1118 | Species | denotes | patients | Tax:9606 |
80 | 1161-1176 | Species | denotes | influenza virus | Tax:11309 |
81 | 1181-1212 | Species | denotes | respiratory syncytial virus); a | Tax:1439707 |
82 | 1367-1388 | Species | denotes | Aspergillus fumigatus | Tax:746128 |
83 | 1441-1449 | Species | denotes | patients | Tax:9606 |
84 | 1339-1352 | Chemical | denotes | galactomannan | MESH:C012990 |
85 | 1124-1132 | Disease | denotes | COVID-19 | MESH:C000657245 |
86 | 1265-1270 | Disease | denotes | fever | MESH:D005334 |
87 | 1537-1555 | Disease | denotes | COVID-19 pneumonia | MESH:C000657245 |
93 | 2732-2740 | Species | denotes | patients | Tax:9606 |
94 | 2789-2797 | Species | denotes | patients | Tax:9606 |
95 | 2753-2762 | Species | denotes | influenza | Tax:11309 |
96 | 2763-2772 | Disease | denotes | pneumonia | MESH:D011014 |
97 | 2823-2832 | Disease | denotes | mortality | MESH:D003643 |
102 | 2869-2877 | Species | denotes | patients | Tax:9606 |
103 | 2892-2896 | Disease | denotes | died | MESH:D003643 |
104 | 2922-2957 | Disease | denotes | acute respiratory distress syndrome | MESH:D012128 |
105 | 2963-2981 | Disease | denotes | multiorgan failure | MESH:D009102 |
113 | 3047-3054 | Species | denotes | patient | Tax:9606 |
114 | 3239-3247 | Species | denotes | patients | Tax:9606 |
115 | 2993-3004 | Species | denotes | Aspergillus | Tax:746128 |
116 | 3015-3026 | Species | denotes | respiratory | Tax:1439707 |
117 | 3104-3113 | Disease | denotes | infection | MESH:D007239 |
118 | 3215-3229 | Disease | denotes | critically ill | MESH:D016638 |
119 | 3230-3238 | Disease | denotes | COVID-19 | MESH:C000657245 |
122 | 3339-3352 | Chemical | denotes | galactomannan | MESH:C012990 |
123 | 3388-3391 | Chemical | denotes | ODI | |
130 | 3537-3545 | Species | denotes | patients | Tax:9606 |
131 | 3574-3588 | Chemical | denotes | amphotericin-B | MESH:D000666 |
132 | 3665-3677 | Chemical | denotes | voriconazole | MESH:D065819 |
133 | 3682-3695 | Chemical | denotes | isavuconazole | MESH:C508735 |
134 | 3610-3628 | Disease | denotes | multiorgan failure | MESH:D009102 |
135 | 3639-3654 | Disease | denotes | hepatic failure | MESH:D017093 |
137 | 3740-3748 | Disease | denotes | COVID-19 | MESH:C000657245 |
143 | 3969-3977 | Species | denotes | patients | Tax:9606 |
144 | 3871-3879 | Disease | denotes | COVID-19 | MESH:C000657245 |
145 | 3891-3923 | Disease | denotes | invasive pulmonary aspergillosis | MESH:D055744 |
146 | 3954-3968 | Disease | denotes | critically ill | MESH:D016638 |
147 | 3990-4008 | Disease | denotes | COVID-19 pneumonia | MESH:C000657245 |
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T1 | 397-405 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
T2 | 433-441 | Body_part | denotes | alveolar | http://purl.org/sig/ont/fma/fma264783 |
T3 | 442-454 | Body_part | denotes | neutrophilic | http://purl.org/sig/ont/fma/fma62860 |
T4 | 1461-1466 | Body_part | denotes | chest | http://purl.org/sig/ont/fma/fma9576 |
T5 | 1723-1728 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T6 | 1925-1930 | Body_part | denotes | serum | http://purl.org/sig/ont/fma/fma63083 |
T7 | 2225-2234 | Body_part | denotes | Leucocyte | http://purl.org/sig/ont/fma/fma62852 |
T8 | 2260-2271 | Body_part | denotes | Lymphocytes | http://purl.org/sig/ont/fma/fma62863 |
T9 | 2429-2436 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T10 | 2444-2457 | Body_part | denotes | interleukin 6 | http://purl.org/sig/ont/fma/fma264829 |
T11 | 2444-2455 | Body_part | denotes | interleukin | http://purl.org/sig/ont/fma/fma86578 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 1461-1466 | Body_part | denotes | chest | http://purl.obolibrary.org/obo/UBERON_0001443 |
T2 | 1723-1728 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
T3 | 1925-1930 | Body_part | denotes | serum | http://purl.obolibrary.org/obo/UBERON_0001977 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 0-32 | Phenotype | denotes | Invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
T2 | 68-77 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T3 | 121-153 | Phenotype | denotes | invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
T4 | 155-158 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T5 | 206-215 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T6 | 350-370 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T7 | 389-412 | Phenotype | denotes | diffuse alveolar damage | http://purl.obolibrary.org/obo/HP_0033006 |
T8 | 647-650 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T9 | 703-712 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T10 | 759-768 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T11 | 825-828 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T12 | 937-946 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T13 | 1033-1053 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T14 | 1265-1270 | Phenotype | denotes | fever | http://purl.obolibrary.org/obo/HP_0001945 |
T15 | 1421-1424 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T16 | 1546-1555 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T17 | 1582-1585 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T18 | 1787-1805 | Phenotype | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/HP_0002206 |
T19 | 2101-2104 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T20 | 2281-2294 | Phenotype | denotes | Renal failure | http://purl.obolibrary.org/obo/HP_0000083 |
T21 | 2330-2362 | Phenotype | denotes | invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
T22 | 2459-2462 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T23 | 2464-2496 | Phenotype | denotes | invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
T24 | 2592-2595 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T25 | 2674-2677 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T26 | 2763-2772 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
T27 | 2928-2948 | Phenotype | denotes | respiratory distress | http://purl.obolibrary.org/obo/HP_0002098 |
T28 | 3145-3148 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T29 | 3431-3434 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T30 | 3518-3521 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T31 | 3639-3654 | Phenotype | denotes | hepatic failure | http://purl.obolibrary.org/obo/HP_0001399 |
T32 | 3760-3763 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
T33 | 3891-3923 | Phenotype | denotes | invasive pulmonary aspergillosis | http://purl.obolibrary.org/obo/HP_0020103 |
T34 | 3999-4008 | Phenotype | denotes | pneumonia | http://purl.obolibrary.org/obo/HP_0002090 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 19-32 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T2 | 43-67 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T3 | 68-77 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T4 | 140-153 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T5 | 200-215 | Disease | denotes | viral pneumonia | http://purl.obolibrary.org/obo/MONDO_0006012 |
T6 | 206-215 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T7 | 296-320 | Disease | denotes | coronavirus disease 2019 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T8 | 322-330 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T9 | 344-379 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T10 | 350-379 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T11 | 573-583 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T12 | 694-702 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T13 | 703-712 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T14 | 749-758 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T15 | 759-768 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T16 | 937-946 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T17 | 957-965 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T18 | 1027-1062 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T19 | 1033-1062 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T20 | 1124-1132 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T21 | 1161-1170 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T22 | 1537-1545 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T23 | 1546-1555 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T24 | 1787-1805 | Disease | denotes | pulmonary fibrosis | http://purl.obolibrary.org/obo/MONDO_0002771 |
T25 | 2026-2034 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T26 | 2157-2160 | Disease | denotes | PCT | http://purl.obolibrary.org/obo/MONDO_0008296|http://purl.obolibrary.org/obo/MONDO_0015104 |
T28 | 2281-2294 | Disease | denotes | Renal failure | http://purl.obolibrary.org/obo/MONDO_0001106 |
T29 | 2349-2362 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T30 | 2483-2496 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T31 | 2554-2557 | Disease | denotes | PCT | http://purl.obolibrary.org/obo/MONDO_0008296|http://purl.obolibrary.org/obo/MONDO_0015104 |
T33 | 2753-2762 | Disease | denotes | influenza | http://purl.obolibrary.org/obo/MONDO_0005812 |
T34 | 2763-2772 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T35 | 2922-2957 | Disease | denotes | acute respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0006502 |
T36 | 2928-2957 | Disease | denotes | respiratory distress syndrome | http://purl.obolibrary.org/obo/MONDO_0009971 |
T37 | 2963-2981 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T38 | 3104-3113 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T39 | 3230-3238 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T40 | 3610-3628 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
T41 | 3740-3748 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T42 | 3871-3879 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T43 | 3910-3923 | Disease | denotes | aspergillosis | http://purl.obolibrary.org/obo/MONDO_0005657 |
T44 | 3990-3998 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T45 | 3999-4008 | Disease | denotes | pneumonia | http://purl.obolibrary.org/obo/MONDO_0005249 |
T46 | 4633-4636 | Disease | denotes | MSD | http://purl.obolibrary.org/obo/MONDO_0010088 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 526-534 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
T2 | 660-661 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T3 | 906-907 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T4 | 1171-1176 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T5 | 1203-1208 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T6 | 1211-1212 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T7 | 1271-1272 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T8 | 1459-1460 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T9 | 1461-1466 | http://www.ebi.ac.uk/efo/EFO_0000965 | denotes | chest |
T10 | 1771-1775 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
T11 | 1771-1775 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
T12 | 1827-1831 | http://purl.obolibrary.org/obo/UBERON_0003101 | denotes | male |
T13 | 1827-1831 | http://www.ebi.ac.uk/efo/EFO_0000970 | denotes | male |
T14 | 2142-2144 | http://purl.obolibrary.org/obo/CLO_0008426 | denotes | pg |
T15 | 2225-2234 | http://purl.obolibrary.org/obo/CL_0000738 | denotes | Leucocyte |
T16 | 2444-2457 | http://purl.obolibrary.org/obo/PR_000001393 | denotes | interleukin 6 |
T17 | 2657-2658 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T18 | 3013-3014 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T19 | 3079-3091 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonization |
T20 | 3291-3298 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | testing |
T21 | 3587-3588 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
T22 | 3776-3777 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T23 | 3927-3928 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T24 | 4057-4060 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T25 | 4172-4175 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T26 | 4260-4263 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T1 | 155-158 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T3 | 647-650 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T5 | 825-828 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T7 | 835-842 | Chemical | denotes | steroid | http://purl.obolibrary.org/obo/CHEBI_35341 |
T8 | 1339-1352 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
T9 | 1421-1424 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T11 | 1582-1585 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T13 | 1681-1694 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
T14 | 1771-1775 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
T15 | 1827-1831 | Chemical | denotes | male | http://purl.obolibrary.org/obo/CHEBI_30780 |
T16 | 1869-1872 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
T17 | 2101-2104 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T19 | 2136-2138 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T21 | 2384-2387 | Chemical | denotes | BAL | http://purl.obolibrary.org/obo/CHEBI_64198 |
T22 | 2429-2436 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T23 | 2438-2440 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
T25 | 2459-2462 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T27 | 2503-2510 | Chemical | denotes | lactate | http://purl.obolibrary.org/obo/CHEBI_24996 |
T28 | 2592-2595 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T30 | 2674-2677 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T32 | 3145-3148 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T34 | 3339-3352 | Chemical | denotes | galactomannan | http://purl.obolibrary.org/obo/CHEBI_27680 |
T35 | 3431-3434 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T37 | 3463-3484 | Chemical | denotes | antifungal medication | http://purl.obolibrary.org/obo/CHEBI_86327 |
T38 | 3463-3473 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
T39 | 3518-3521 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
T41 | 3665-3677 | Chemical | denotes | voriconazole | http://purl.obolibrary.org/obo/CHEBI_10023 |
T42 | 3682-3695 | Chemical | denotes | isavuconazole | http://purl.obolibrary.org/obo/CHEBI_85979 |
T43 | 3760-3763 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 1357-1363 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | growth |
T2 | 2983-2989 | http://purl.obolibrary.org/obo/GO_0040007 | denotes | Growth |
LitCovid-PD-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glyco_epitope_db_id |
---|---|---|---|---|---|
T1 | 1339-1352 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
T2 | 1681-1694 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
T3 | 1850-1863 | GlycoEpitope | denotes | Galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
T4 | 1906-1919 | GlycoEpitope | denotes | Galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
T5 | 3339-3352 | GlycoEpitope | denotes | galactomannan | http://www.glycoepitope.jp/epitopes/EP0510 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-77 | Sentence | denotes | Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia |
T2 | 79-93 | Sentence | denotes | To the editor, |
T3 | 94-247 | Sentence | denotes | Superinfections, including invasive pulmonary aspergillosis (IPA), are well-known complications of severe viral pneumonia in critically ill patients [1]. |
T4 | 248-590 | Sentence | denotes | Pathological studies of individuals with severe coronavirus disease 2019 (COVID-19) -associated acute respiratory distress syndrome reported diffuse alveolar damage combined with intra-alveolar neutrophilic infiltration and vascular congestion, assuming an impaired mucociliary activity that might pave the way for secondary infections [2,3]. |
T5 | 591-769 | Sentence | denotes | Our report of two critically ill patients suggests that IPA might be a relevant complication of severe COVID-19 pneumonia in analogy to experiences in severe influenza pneumonia. |
T6 | 770-1063 | Sentence | denotes | Both individuals were without typical risk factors for IPA, e.g. steroid medication or other immunospuppression, and were admitted from a secondary-care hospital with pneumonia caused by COVID-19 to our intensive care unit (ICU) after progression to severe acute respiratory distress syndrome. |
T7 | 1064-1436 | Sentence | denotes | In the initial bronchoalveolar lavage of both patients only COVID-19 was found (PCR negative for influenza virus and respiratory syncytial virus); a follow-up bronchoalveolar lavage because of ongoing fever a few days later (days 5 and 6 after ICU admission) showed elevated galactomannan and growth of Aspergillus fumigatus in standard culture, suggesting IPA (Table 1 ). |
T8 | 1437-1586 | Sentence | denotes | All patients received a chest computed tomography scan before ICU admittance with typical signs for COVID-19 pneumonia but no specific signs for IPA. |
T9 | 1587-1661 | Sentence | denotes | Follow-up computed tomography scans were not performed for safety reasons. |
T10 | 1662-1750 | Sentence | denotes | Table 1 Results of galactomannan (bronchoalveolar lavage and serum) and standard culture |
T11 | 1751-1849 | Sentence | denotes | Patient 1(80 years, male, suspected pulmonary fibrosis) Patient 2(70 years, male, no risk factors) |
T12 | 1850-1905 | Sentence | denotes | Galactomannan from BAL (ODI; normal range <1.0) 6.3 6.1 |
T13 | 1906-1964 | Sentence | denotes | Galactomannan from serum (ODI; normal range <0.5) 1.5 <0.5 |
T14 | 1965-2025 | Sentence | denotes | Standard culture Aspergillus fumigatus Aspergillus fumigatus |
T15 | 2026-2069 | Sentence | denotes | SARS-CoV-2 (at follow up) positive positive |
T16 | 2070-2114 | Sentence | denotes | Laboratory parameters, mean at IPA diagnosis |
T17 | 2115-2134 | Sentence | denotes | CRP (mg/dL) 26 5.1 |
T18 | 2135-2155 | Sentence | denotes | IL-6 (pg/mL) 460 82 |
T19 | 2156-2176 | Sentence | denotes | PCT (ng/mL) 3.7 0.4 |
T20 | 2177-2204 | Sentence | denotes | D-Dimer (μg/L) 4820 14 151 |
T21 | 2205-2223 | Sentence | denotes | LDH (U/L) 481 530 |
T22 | 2224-2258 | Sentence | denotes | Leucocyte count (G/L) 10.38 14.55 |
T23 | 2259-2280 | Sentence | denotes | Lymphocytes (%) 15 7 |
T24 | 2281-2302 | Sentence | denotes | Renal failure Yes Yes |
T25 | 2303-2368 | Sentence | denotes | Classical risk factors for invasive pulmonary aspergillosis No No |
T26 | 2369-2573 | Sentence | denotes | Abbreviations: BAL, bronchoalveolar lavage; CRP, C-reactive protein; IL-6, interleukin 6; IPA, invasive pulmonary aspergillosis; LDH, lactate dehydrogenase; ODI, optical density index; PCT, procalcitonin. |
T27 | 2574-2779 | Sentence | denotes | The time-point of IPA diagnosis is in line with previous studies that demonstrated a median time to IPA diagnosis between 3 and 9 days after ICU admission of patients with severe influenza pneumonia [1,3]. |
T28 | 2780-2863 | Sentence | denotes | In these patients also, high incidence and mortality rates could be observed [1,3]. |
T29 | 2864-2982 | Sentence | denotes | Both patients in our report died as the result of ongoing acute respiratory distress syndrome with multiorgan failure. |
T30 | 2983-3114 | Sentence | denotes | Growth of Aspergillus spp. in a respiratory culture from an ICU patient is often interpreted as colonization rather than infection. |
T31 | 3115-3268 | Sentence | denotes | Other typical diagnostics for IPA, such as biopsy or imaging techniques, may be more challenging in critically ill COVID-19 patients for several reasons. |
T32 | 3269-3441 | Sentence | denotes | Therefore, additional testing of bronchoalveolar lavage specimens for galactomannan is easy, and the specificity of an ODI cut-off of >1·0 is about 90% to detect IPA [4,5]. |
T33 | 3442-3532 | Sentence | denotes | Early and sufficient antifungal medication is the cornerstone for effective IPA treatment. |
T34 | 3533-3724 | Sentence | denotes | Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives. |
T35 | 3725-3828 | Sentence | denotes | In conclusion, COVID-19-associated IPA may lead to a poor outcome even in immune competent individuals. |
T36 | 3829-4009 | Sentence | denotes | Further studies are needed to indicate if COVID-19-associated invasive pulmonary aspergillosis is a relevant complication in critically ill patients with severe COVID-19 pneumonia. |
T37 | 4011-4036 | Sentence | denotes | Transparency declarations |
T38 | 4037-4151 | Sentence | denotes | None of the authors has any potential financial or non-financial conflicts of interest related to this manuscript. |
T39 | 4152-4244 | Sentence | denotes | None of the authors has received any funding or financial support regarding this manuscript. |
T40 | 4245-4305 | Sentence | denotes | The manuscript has not been submitted or accepted elsewhere. |
T41 | 4306-4372 | Sentence | denotes | All authors fulfil the criteria given in the authorship paragraph. |
T42 | 4373-4469 | Sentence | denotes | No writing assistance other than copy editing was provided in the preparation of the manuscript. |
T43 | 4471-4487 | Sentence | denotes | Research funding |
T44 | 4488-4507 | Sentence | denotes | Nothing to declare. |
T45 | 4509-4533 | Sentence | denotes | Employment or leadership |
T46 | 4534-4553 | Sentence | denotes | Nothing to declare. |
T47 | 4554-4637 | Sentence | denotes | Tobias Lahmer received travel grants from 10.13039/100004319Pfizer, Gilead and MSD. |